Wang, H., Yang, J., Pan, H., Tai, M. C., Maher, M. H., Jia, R., . . . Lu, L. (2020). Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway. Onco Targets Ther.
Stile di citazione ChicagoWang, Huixue, Jie Yang, Hui Pan, Mei Chee Tai, Mohamed H. Maher, Renbing Jia, Shengfang Ge, e Linna Lu. "Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway." Onco Targets Ther 2020.
Citazione MLAWang, Huixue, et al. "Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway." Onco Targets Ther 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.